Formed in 2020, MediMusic is a B2B service that uses artificial intelligence and machine learning to create audio fingerprints which mimic the human brain’s response to music and then scientifically dispenses it as an efficacy-driven medicine for the benefit of clinical pain and anxiety.

We auto-create personalised, smart playlists that use predictive analysis to reduce heart rate and the stress hormone cortisol, thereby promoting positive endocrine secretions – such as Dopamine, Immunoglobin-A and Oxytocin – as well as improving breathing and cognitive response.

Whilst listening to the chosen music via our app, the user heart rate response can be monitored for playlist refinement purposes, via our Digital Drip® bio feedback loop, and evidence-based ROI and multiple cost-saving KPIs are provided for healthcare services.

Our beachhead market is dementia, pre/post op pain & anxiety, dental anxiety into the NHS, care homes and employee benefit programmes.

2023 Finalists